Trial Profile
Clinical Trials Insight: 700021859
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2007
Price :
$35
*
At a glance
- Drugs Glufosfamide (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors MediBIC; Threshold Pharmaceuticals
- 22 Mar 2007 New trial record.